Just weeks after its landmark 50-for-1 stock split made shares more affordable for employees and a broader base of investors, ...

In the latest close session, Onto Innovation (ONTO) was down 1.08% at $101.76. This change lagged the S&P 500's 0.33% loss on the day. Meanwhile, the Dow experienced a drop of 0.63%, and the ...

HSBC analyst Frank Lee just upgraded Advanced Micro Devices (AMD) from “Hold” to “Buy,” doubling its price target from $100 to $200 per share, implying a 44.5% upside from the stock’s closing price of ...

Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.

Meta’s $100 million sign-up bonuses have underscored the value of cutting-edge tech talent. Indian businesses should also be ...

Excitement over the potential of AI has driven much of the appreciation in global markets in recent years, with the ...

Traders have repeatedly shrugged off President Trump’s disruptive tariff wars and fiscal policy, pushing U.S. stock prices ...

After Glenmark’s landmark $2 billion licensing deal with US major AbbVie for its cancer drug, ISB 2001, the stock hit the 10% ...

From time to time, investors like to look for fresh insights outside the world of markets. In the latest piece for his ...

Discover how Citadel Securities solidifies its dominance in market-making with a key acquisition from Morgan Stanley.